Home/Filings/4/0001127602-24-014505
4//SEC Filing

Busch Matthew C. 4

Accession 0001127602-24-014505

CIK 0000318154other

Filed

May 6, 8:00 PM ET

Accepted

May 7, 8:31 PM ET

Size

5.4 KB

Accession

0001127602-24-014505

Insider Transaction Report

Form 4
Period: 2024-05-05
Busch Matthew C.
VP, Finance & CAO
Transactions
  • Tax Payment

    Common Stock

    2024-05-05$311.29/sh27$8,4054,599 total
Footnotes (2)
  • [F1]These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 43 RSUs which will vest on 4/30/2025; 1,003 RSUs which will vest in installments of 494 on 11/5/2024 and 509 on 11/5/2025; 144 RSUs which will vest in installments of 71 on 5/2/2025, and 73 on 5/2/2026; and 296 RSUs which will vest in installments of 97 on 5/2/2025, 98 on 5/2/2026 and 101 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
  • [F2]These shares include 112 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Issuer

AMGEN INC

CIK 0000318154

Entity typeother

Related Parties

1
  • filerCIK 0001987926

Filing Metadata

Form type
4
Filed
May 6, 8:00 PM ET
Accepted
May 7, 8:31 PM ET
Size
5.4 KB